Gut Bacteria Provide Genetic and Molecular Reporter Systems to Identify Specific Diseases
- PMID: 38674014
- PMCID: PMC11050607
- DOI: 10.3390/ijms25084431
Gut Bacteria Provide Genetic and Molecular Reporter Systems to Identify Specific Diseases
Abstract
With genetic information gained from next-generation sequencing (NGS) and genome-wide association studies (GWAS), it is now possible to select for genes that encode reporter molecules that may be used to detect abnormalities such as alcohol-related liver disease (ARLD), cancer, cognitive impairment, multiple sclerosis (MS), diabesity, and ischemic stroke (IS). This, however, requires a thorough understanding of the gut-brain axis (GBA), the effect diets have on the selection of gut microbiota, conditions that influence the expression of microbial genes, and human physiology. Bacterial metabolites such as short-chain fatty acids (SCFAs) play a major role in gut homeostasis, maintain intestinal epithelial cells (IECs), and regulate the immune system, neurological, and endocrine functions. Changes in butyrate levels may serve as an early warning of colon cancer. Other cancer-reporting molecules are colibactin, a genotoxin produced by polyketide synthetase-positive Escherichia coli strains, and spermine oxidase (SMO). Increased butyrate levels are also associated with inflammation and impaired cognition. Dysbiosis may lead to increased production of oxidized low-density lipoproteins (OX-LDLs), known to restrict blood vessels and cause hypertension. Sudden changes in SCFA levels may also serve as a warning of IS. Early signs of ARLD may be detected by an increase in regenerating islet-derived 3 gamma (REG3G), which is associated with changes in the secretion of mucin-2 (Muc2). Pro-inflammatory molecules such as cytokines, interferons, and TNF may serve as early reporters of MS. Other examples of microbial enzymes and metabolites that may be used as reporters in the early detection of life-threatening diseases are reviewed.
Keywords: diseases; gut microbiota; reporter systems.
Conflict of interest statement
The author declares no conflict of interest.
Figures








Similar articles
-
Gastrointestinal Tract, Microbiota and Multiple Sclerosis (MS) and the Link Between Gut Microbiota and CNS.Curr Microbiol. 2022 Dec 17;80(1):38. doi: 10.1007/s00284-022-03150-7. Curr Microbiol. 2022. PMID: 36527519 Review.
-
The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?Front Immunol. 2021 Sep 21;12:718220. doi: 10.3389/fimmu.2021.718220. eCollection 2021. Front Immunol. 2021. PMID: 34621267 Free PMC article. Review.
-
Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases.Int J Mol Sci. 2023 Feb 9;24(4):3494. doi: 10.3390/ijms24043494. Int J Mol Sci. 2023. PMID: 36834904 Free PMC article. Review.
-
Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.J Physiol. 2018 Oct;596(20):4923-4944. doi: 10.1113/JP276431. Epub 2018 Aug 28. J Physiol. 2018. PMID: 30066368 Free PMC article.
-
Short chain fatty acids: Microbial metabolites for gut-brain axis signalling.Mol Cell Endocrinol. 2022 Apr 15;546:111572. doi: 10.1016/j.mce.2022.111572. Epub 2022 Jan 20. Mol Cell Endocrinol. 2022. PMID: 35066114 Review.
Cited by
-
Gut Microbiota in Heart Failure-The Role of Inflammation.Biomedicines. 2025 Apr 9;13(4):911. doi: 10.3390/biomedicines13040911. Biomedicines. 2025. PMID: 40299538 Free PMC article. Review.
-
Internet-Based Abnormal Chromosomal Diagnosis During Pregnancy Using a Noninvasive Innovative Approach to Detecting Chromosomal Abnormalities in the Fetus: Scoping Review.JMIR Bioinform Biotechnol. 2024 Oct 16;5:e58439. doi: 10.2196/58439. JMIR Bioinform Biotechnol. 2024. PMID: 39412876 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous